论文部分内容阅读
目的:观察Spinocath导管鞘内连续给药分娩镇痛对孕妇及胎儿的影响。方法:选择80例初产妇随机分为分娩镇痛组(A组)和对照组(B组)各40例,观察产妇的生命体征、产程时间、分娩方式、宫缩情况、缩宫素使用情况、产后出血、胎心监护、脐血流、羊水性状、新生儿Apgar评分、脐动脉血气分析。结果:两组在生命体征、产程时间、产后出血、胎心监护、脐血流、羊水性状、新生儿Apgar评分、脐动脉血气分析方面比较差异无统计学意义(P>0.05);A组剖宫产率较B组低,A组自然分娩率、出现宫缩乏力及缩宫素使用比B组高,差异有统计学意义(P<0.05)。结论:微量舒芬太尼Spinocath导管鞘内连续给药分娩镇痛对母婴无不良影响,但要注意预防出现子宫收缩乏力。
OBJECTIVE: To observe the effects of Spinocath intra-ductal intrathecal administration of labor analgesia on pregnant women and fetus. Methods: Eighty primiparous women were randomly divided into labor analgesia group (group A) and control group (group B), 40 patients. The vital signs, labor duration, delivery mode, contractions and oxytocin , Postpartum hemorrhage, fetal heart rate monitoring, cord blood flow, amniotic fluid traits, neonatal Apgar score, umbilical artery blood gas analysis. Results: There was no significant difference between the two groups in vital signs, labor duration, postpartum hemorrhage, fetal heart rate monitoring, umbilical blood flow, amniotic fluid traits, neonatal Apgar score and umbilical arterial blood gas analysis (P> 0.05) Palace production rate is lower than B group, A group of natural delivery rate, uterine inertia and oxytocin use than the B group, the difference was statistically significant (P <0.05). CONCLUSION: Continuous intravenous injection of Spinocath with trace sufentanil has no adverse effect on maternal and infant analgesia during childbirth. However, we should pay attention to the prevention of uterine atony.